Justine V Cohen

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Squamous Cell Carcinoma

Top Venues

Cancer research communications

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications 4 (5) (2024)
Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II study of ERK inhibition by ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications (2024)
Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II study of ERK inhibition by ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications (2024)
Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications 4 (5) (2024)
Takuto Sato, Kamaneh Montazeri, Evangelos S Gragoudas, Anne Marie Lane, Mary Beth Aronow, Justine V Cohen, Genevieve Marie Boland, Eric Banks, Christopher Kachulis, Mark Fleharty, Carrie Cibulskis, Aleigha Lawless, Viktor A Adalsteinsson, Ryan J Sullivan, Ivana K Kim
Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal Melanoma. JCO precision oncology 8 (2024)
Meghan J Mooradian, James M Cleary, Anita Giobbie-Hurder, Lancia N F Darville, Aparna Raj Parikh, Elizabeth I Buchbinder, Justine V Cohen, Donald P Lawrence, Geoffrey I Shapiro, Harold Keer, Helen X Chen, Susan Percy Ivy, Keiran S M Smalley, John M Koomen, Ryan J Sullivan
Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumors. Cancer (2023)
Justine V Cohen, Nancy Wang, Vyshak A Venur, Matthew J Hadfield, Daniel P Cahill, Kevin Oh, Priscilla K Brastianos
Neurologic complications of melanoma. Cancer 126 (3) (2019)